Transition metals are cofactors for a wide range of vital enzymes and are directly or indirectly involved in the response against reactive oxygen species (ROS), which can damage cellular components. Their altered homeostasis has been studied in neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), but no data are available on rarer conditions. We aimed at studying the role of essential trace elements in ataxia telangiectasia (A-T), a rare form of pediatric autosomal recessive cerebellar ataxia with altered antioxidant response. We found an increased level of copper (Cu, p = 0.0002) and a reduced level of zinc (Zn, p = 0.0002) in the blood of patients (n. 16) compared to controls, using inductively coupled plasma mass spectrometry (ICP-MS). Other trace elements involved in the oxidative stress response, such as manganese (Mn) and selenium (Se), were unaltered. Cu/Zn-dependent superoxide dismutase (SOD1) was shown to have a 30% reduction in gene expression and 40% reduction in enzyme activity upon analysis of lymphoblastoid cell lines of patients (Student's t-test, p = 0.0075). We also found a 30% reduction of Mn-SOD (SOD2; Student's t-test, p = 0.02), probably due to a feedback regulatory loop between the two enzymes. The expression of antioxidant enzymes, such as erythrocyte glutathione peroxidase (GPX1), and SOD2 was unaltered, whereas catalase (CAT) was increased in A-T cells, both at the mRNA level and in terms of enzyme activity (~25%). Enhanced CAT expression can be attributed to the high ROS status, which induces CAT transcription. These results suggest that alterations in essential trace elements and their related enzymes may play a role in the pathogenesis of A-T, although we cannot conclude if altered homeostasis is a direct effect of A-T mutated genes (ATM). Altered homeostasis of trace elements may be more prevalent in neurodegenerative diseases than previously thought, and it may represent both a biomarker and a generic therapeutic target for different disorders with the common theme of altered antioxidant enzyme responses associated with an unbalance of metals.
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Introduction
Ataxia telangiectasia (A-T) is an autosomal recessive multisystem disorder with a frequency of 1/40,000-1/100,000 (Swift et al., 1986) . Main clinical features include progressive cerebellar degeneration leading to severe neuromotor dysfunction, oculocutaneous telangiectasia, profound immunodeficiency of both humoral and cellular compartments, gonadal dysgenesis, growth retardation in some patients, predisposition to malignancies (primarily lymphoreticular), high levels of serum alpha-fetoprotein and acute radiosensitivity. A-T cells show chromosomal instability, premature senescence, accelerated telomere shortening, sensitivity to the cytotoxic and clastogenic effects of ionizing radiation and radiomimetic chemicals and defective activation of cell cycle checkpoints by these agents (Boder and Sedgwick, 1970; Gatti, 2001; Shiloh, 2006) . The A-T mutated gene (ATM) encodes for a serine/threonine protein kinase recruited and activated by DNA double-strand breaks. ATM phosphorylates several key proteins that initiate the activation of DNA damage checkpoints, leading to cell cycle arrest, DNA repair or apoptosis. Although the neurodegenerative phenotype has been attributed to a defective response to DNA breaks in pre-and post-mitotic neurons (Lee et al., 2001) , oxidative stress and reduced antioxidant defence may also play a role (Biton et al., 2006) .
The correlation of the A-T phenotype with oxidative stress has been determined by molecular, in vitro and animal studies. A-T patients show persistent oxidative stress at the cellular level, and ATM knockout mice exhibit increased signatures of reactive oxygen species (ROS) 
